Tenaya Therapeutics (TNYA) Receivables - Other (2022)
Tenaya Therapeutics (TNYA) recorded quarterly Receivables - Other of $2.0 million in Q4 2022, little changed quarter-over-quarter from $2.0 million in Q2 2022.
Tenaya Therapeutics (TNYA) Receivables - Other (2022) Analysis & Trends
Tenaya Therapeutics' Receivables - Other history runs 1 years deep, the most recent figure standing at $2.0 million for Q4 2022.
- In Q4 2022, Receivables - Other changed N/A year-over-year to $2.0 million; the TTM figure through Dec 2022 stood at $2.0 million (changed N/A YoY), while the FY2022 annual figure was $2.0 million, changed N/A from the prior year.
- Receivables - Other was $2.0 million for Q4 2022 at Tenaya Therapeutics, roughly flat from $2.0 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $2.0 million in Q2 2022 to a low of $2.0 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Tenaya Therapeutics | 158.32 Mn | 158.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 2.00 Mn |
| Dec 31, 2022 | 2.00 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 2.00 Mn |